Remove Drug Development Remove Molecular Biology Remove Pharma Companies
article thumbnail

Europe: Where is the drug discovery innovation?

Drug Discovery World

Even before this, however, Amsterdam was established as an important centre for drug development. Under the partnership, KWF will provide funding to enable the development of select early phase clinical programmes through Cancer Research UK’s Centre for Drug Development (CDD).

Drugs 148
article thumbnail

What is the largest CRO in the US?

Vial

Leading Global CROs To advance new therapies, pharma, biotech, and medical device sponsors engage CROs to help navigate the complex landscape of drug development and regulatory pathways and to manage clinical trials efficiently, ethically, and in compliance with good clinical practice ( GCP ) standards. of total revenue).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Synthetic biology tools advancing and accelerating drug discovery efforts

Drug Discovery World

As such, the synthesis of DNA oligonucleotides for routine molecular biology applications is often outsourced to service provider companies that operate DNA synthesisers to meet these demands. . Synthetic libraries for antibody drug discovery .

DNA 246
article thumbnail

AI At The Frontier: Empowering Early Career Professionals In Drug Discovery

Elrig

She is involved in the research and development of cellular assays across multiple research areas for live-cell analysis applications, including AI-based image analysis tools. You’ll also need to understand machine learning, which is a big part of using artificial intelligence in drug discovery. big pharma or startups/spin off?

article thumbnail

What it takes to make cancer research more inclusive

Drug Discovery World

These observations may come to light in the clinic, but these disparities can be attributed to every phase of the drug development pipeline – clinical trials, translational research and, ultimately, drug discovery. . Instead, molecular markers are more accurate indicators of the patient’s associated risks. .

Research 130
article thumbnail

Scaling Phage Therapy

Codon

Because frankly, do you know of anything else that can work against multiple drug-resistant bacteria? ” A Global View Even as advances in computing and molecular biology usher in the era of a new, high-tech “phage therapy 2.0”,

Therapies 124